Differential expression of IFN-α, IL-12 and BAFF on renal immune cells and its relevance to disease activity and treatment responsiveness in patients with proliferative lupus nephritisAya Nawata, Shingo Nakayamada, Satoshi Hisano, Yusuke Miyazaki, Tetsu Miyamoto, Eisuke Shiba, Masanori Hisaoka, Yoshiya Tanaka
17 July 2023
Remission of lupus nephritis: the trajectory of histological response in successfully treated patientsAna Malvar, Valeria Alberton, Bruno Lococo, Maria Lourenco, Joaquin Martinez, Lucrecia Burna, Celeste Besso, Jordi Navarro, Haikady N Nagaraja, Aastha Khatiwada, Bethany Wolf, Brad Rovin
31 May 2023
Glomerular mTORC1 activation was associated with podocytes to endothelial cells communication in lupus nephritisXiaotian Liu, Zhaomin Mao, Mo Yuan, Linlin Li, Ying Tan, Zhen Qu, Min Chen, Feng Yu
5 May 2023
Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritisAhmad Akhgar, Dominic Sinibaldi, Lingmin Zeng, Alton B Farris III, Jason Cobb, Monica Battle, David Chain, Jennifer A Cann, Gábor G Illei, S Sam Lim, Wendy I White
30 January 2023
Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trialsIan N Bruce, Ronald F van Vollenhoven, Konstantina Psachoulia, Catharina Lindholm, Emmanuelle Maho, Raj Tummala
13 January 2023
Response to therapy at 6 months predicts long-term renal outcome in lupus nephritis with poor kidney functionHuiting Luo, Yangzhong Zhou, Gang Chen, Qidong Ren, Jiuliang Zhao, Wenling Ye, Yan Qin, Xuemei Li
29 December 2022
Molecular signatures of intrarenal complement receptors C3AR1 and C5AR1 correlate with renal outcome in human lupus nephritisDésirée Tampe, Samy Hakroush, Björn Tampe
15 December 2022
Mer-tyrosine kinase: a novel susceptibility gene for SLE related end-stage renal diseaseSule Yavuz, Pascal Pucholt, Johanna K Sandling, Matteo Bianchi, Dag Leonard, Karin Bolin, Juliana Imgenberg-Kreuz, Maija-Leena Eloranta, Sergey V Kozyrev, Cristina M Lanata, Andreas Jönsen, Anders A Bengtsson, Christopher Sjöwall, Elisabet Svenungsson, Iva GunnarssonSee the full list of authors
4 November 2022
Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritisAliisa Häyry, Francesca Faustini, Agneta Zickert, Anders Larsson, Timothy B Niewold, Elisabet Svenungsson, Vilija Oke, Iva Gunnarsson
14 September 2022
MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorTKenei Sada, Noriaki Kurita, Hisashi Noma, Taizo Matsuki, Holly Quasny, Roger A Levy, Angela R Jones-Leone, Kerry Gairy, Nobuyuki Yajima
1 September 2022